ENTRY       D00599                      Drug
NAME        Carteolol hydrochloride (JP18/USP);
            Cartrol (TN);
            Ocupress (TN)
PRODUCT
  GENERIC   CARTEOLOL HYDROCHLORIDE (Sandoz)
FORMULA     C16H24N2O3. HCl
EXACT_MASS  328.1554
MOL_WEIGHT  328.8343
CLASS       Cardiovascular agent
             DG01466  Adrenergic receptor antagonist
              DG01464  beta-Adrenergic receptor antagonist (Beta blocker)
             DG01653  Antiarrhythmics
              DG01806  Class II antiarrhythmic agent
             DG03231  Antihypertensive
            Ophthalmic agent
             DG03201  Intraocular pressure lowering agent
            Metabolizing enzyme substrate
             DG01644  CYP2D6 substrate
REMARK      Therapeutic category: 1319 2123 2149
            ATC code: C07AA15 S01ED05
            Chemical structure group: DG00308
            Product (DG00308): D00599<JP/US>
            Product (mixture): D10804<JP>
EFFICACY    Antiglaucoma, Antiarrhythmic, Antihypertensive, beta-Adrenergic receptor antagonist
  DISEASE   Chronic open-angle glaucoma [DS:H00612]
COMMENT     Propranolol derivative
TARGET      ADRB [HSA:153 154 155] [KO:K04141 K04142 K04143]
  PATHWAY   hsa04020(153+154+155)  Calcium signaling pathway
            hsa04022(153+154+155)  cGMP-PKG signaling pathway
            hsa04024(153+154)  cAMP signaling pathway
            hsa04080(153+154+155)  Neuroactive ligand-receptor interaction
            hsa04261(153+154)  Adrenergic signaling in cardiomyocytes
            hsa04540(153)  Gap junction
METABOLISM  Enzyme: CYP2D6 [HSA:1565]
INTERACTION  
STR_MAP     map07054  Antiglaucoma agents
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             C CARDIOVASCULAR SYSTEM
              C07 BETA BLOCKING AGENTS
               C07A BETA BLOCKING AGENTS
                C07AA Beta blocking agents, non-selective
                 C07AA15 Carteolol
                  D00599  Carteolol hydrochloride (JP18/USP) &lt;JP/US&gt;
             S SENSORY ORGANS
              S01 OPHTHALMOLOGICALS
               S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS
                S01ED Beta blocking agents
                 S01ED05 Carteolol
                  D00599  Carteolol hydrochloride (JP18/USP) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Ophthalmic Agents
              Intraocular Pressure Lowering Agents
               Beta-adrenergic Blocking Agents, Ophthalmic
                Carteolol
                 D00599  Carteolol hydrochloride (JP18/USP)
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              13  Agents affecting sensory organs
               131  Ophthalmic agents
                1319  Others
                 D00599  Carteolol hydrochloride (JP18/USP)
             2  Agents affecting individual organs
              21  Cardiovascular agents
               212  Antiarrhythmic agents
                2123  Beta blockers
                 D00599  Carteolol hydrochloride (JP18/USP)
               214  Antihypertensives
                2149  Others
                 D00599  Carteolol hydrochloride (JP18/USP)
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01466  Adrenergic receptor antagonist
               DG01464  beta-Adrenergic receptor antagonist (Beta blocker)
                DG00308  Carteolol
                 D00599  Carteolol hydrochloride
              DG01653  Antiarrhythmics
               DG01806  Class II antiarrhythmic agent
                DG00308  Carteolol
                 D00599  Carteolol hydrochloride
              DG03231  Antihypertensive
               DG00308  Carteolol
                D00599  Carteolol hydrochloride
             Ophthalmic agent
              DG03201  Intraocular pressure lowering agent
               DG00308  Carteolol
                D00599  Carteolol hydrochloride
             Metabolizing enzyme substrate
              DG01644  CYP2D6 substrate
               DG00308  Carteolol
                D00599  Carteolol hydrochloride
            Drug classes [BR:br08332]
             Cardiovascular agent
              DG03231  Antihypertensive
               D00599  Carteolol hydrochloride
              DG01653  Antiarrhythmics
               D00599  Carteolol hydrochloride
             Ophthalmic agent
              DG03201  Intraocular pressure lowering agent
               D00599  Carteolol hydrochloride
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Adrenaline
                ADRB
                 D00599  Carteolol hydrochloride (JP18/USP) &lt;JP/US&gt;
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00599  Carteolol hydrochloride
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D00599
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01466  Adrenergic receptor antagonist
               DG01464  beta-Adrenergic receptor antagonist (Beta blocker)
                DG00308  Carteolol
              DG01653  Antiarrhythmics
               DG01806  Class II antiarrhythmic agent
                DG00308  Carteolol
              DG03231  Antihypertensive
               DG00308  Carteolol
             Ophthalmic agent
              DG03201  Intraocular pressure lowering agent
               DG00308  Carteolol
             Metabolizing enzyme substrate
              DG01644  CYP2D6 substrate
               DG00308  Carteolol
DBLINKS     CAS: 51781-21-6
            PubChem: 7847665
            ChEBI: 3438
            LigandBox: D00599
            NIKKAJI: J299.331G
ATOM        22
            1   X   Cl   34.1717  -16.9041
            2   C1x C    24.1844  -15.2181
            3   C5x C    24.1844  -16.6229
            4   N1x N    25.4010  -17.3254
            5   C8y C    26.6177  -16.6229
            6   C8y C    26.6177  -15.2181
            7   C1x C    25.4010  -14.5157
            8   C8x C    27.8343  -17.3254
            9   C8x C    29.0509  -16.6229
            10  C8x C    29.0509  -15.2181
            11  C8y C    27.8343  -14.5157
            12  O5x O    22.9678  -17.3254
            13  O2a O    27.8343  -13.1108
            14  C1b C    29.0530  -12.4072
            15  C1c C    30.2536  -13.1006
            16  C1b C    31.4445  -12.4130
            17  O1a O    30.2537  -14.5154
            18  N1b N    32.6401  -13.1036
            19  C1d C    33.8337  -12.4145
            20  C1a C    35.0333  -11.7219
            21  C1a C    34.5265  -13.6153
            22  C1a C    33.1223  -11.1820
BOND        22
            1     2   3 1
            2     3   4 1
            3     4   5 1
            4     5   6 1
            5     6   7 1
            6     2   7 1
            7     5   8 2
            8     8   9 1
            9     9  10 2
            10   10  11 1
            11    6  11 2
            12    3  12 2
            13   11  13 1
            14   13  14 1
            15   14  15 1
            16   15  16 1
            17   15  17 1
            18   16  18 1
            19   18  19 1
            20   19  20 1
            21   19  21 1
            22   19  22 1
///
